What the UK’s Novel Foods Milestone Means for the Future of CBD: A Call for US Regulatory Change

This is more than just a regulatory checkbox—it’s a critical step towards establishing a safer, more reliable global CBD marketplace. While the UK is taking strides to regulate its market, the US lags behind, leaving many to wonder: What’s next for CBD regulation in the US? There is a growing call for US regulatory change to address this lag.

Let’s explore what this milestone means for global trade, consumer safety, and why the US should be paying attention.

What is the UK’s Novel Foods Process and Why Does it Matter?

The UK’s Novel Foods regulation requires detailed safety assessments for any products not commonly consumed before May 1997. For CBD manufacturers, it’s a rigorous but necessary process to ensure that products meet safety standards before they’re available on the market.

At Mile High Labs, achieving this milestone is a validation of our commitment to quality and regulatory compliance. But it’s also a message to the global CBD market: We’re ready for what’s next.

A Call for US Regulatory Change for CBD Standards

What’s Happening in the US?

Unlike the UK, the US currently operates in a regulatory gray area when it comes to CBD. The lack of federal oversight creates inconsistent standards and risks for consumers.

Some key differences between the US and UK markets include:

Safety Requirements: The UK mandates detailed safety testing, while the US varies by state, leading to gaps in product quality.
Consistency Across Regions: The UK’s uniform standards create predictable outcomes for manufacturers. In contrast, US companies face a patchwork of local regulations.
Consumer Confidence: UK consumers can trust that approved products have been thoroughly vetted. In the US, uncertainty remains.

What can the US learn from the UK’s approach?

If the US wants to protect consumers and expand its global footprint, it needs a similar commitment to regulation.

Global Trade: Why Regulation Matters

Regulation isn’t just about consumer safety—it’s a competitive advantage in the global marketplace. Companies like Mile High Labs that meet international standards are already positioned to export globally, opening opportunities in markets with strict requirements like Japan, the EU, and now the UK.

Global Shipping and Regulatory Standards

The Role of US Companies in Global CBD Export

Mile High Labs has been a pioneer in navigating global certifications and regulatory approvals. Our experience highlights how companies like MHL can lead the charge if they embrace international standards. With the USA being the founders of this industry, we should be leading the drive for global regulation and compliance. But here’s the catch: Without a robust regulatory framework in the US, many companies could be left behind. As global markets tighten their standards, those that don’t comply risk losing access to key regions.

The Big Question: Will the US Follow Suit?

The UK has proven that regulated CBD markets are possible. Could the US be next? Or will it continue to miss out on the benefits of a safer, globally competitive industry?

Why Should You Care?

This isn’t just about policy—it’s about the future of the CBD industry. If the US doesn’t step up, companies could face:

Limited export opportunities
Inconsistent product quality and safety risks
A growing gap between international standards and domestic production

Do we really want to be left behind while other countries move forward?

Gloves Off: What Comes Next

It’s time for the US to take regulation seriously. The UK has shown that when companies play by the rules, everyone wins—consumers, manufacturers, and regulators alike. So, why not here?

Let’s drive the conversation forward. Regulation isn’t a hurdle—it’s an opportunity. With leadership and commitment, the US CBD market can thrive on a global scale.